Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie W Krashin

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Opinion in Obstetrics & Gynecology|October 3, 2024
Patient navigation in reproductive healthcareMelissa Schechter, Eve Espey, Jamie W Krashin
Obstetrics and Gynecology Clinics of North America|July 27, 2023
Vaginal Bleeding Before 20 Weeks GestationBrenna Banwarth-Kuhn, Miriam McQuade, Jamie W Krashin
American Journal of Obstetrics and Gynecology|December 7, 2025
Patients prioritize choice for postpartum contraceptionJamie W Krashin, Timothy R Petersen, Eve Espey
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|March 28, 2026
The Shifting Policy Landscape in Reproductive HealthMindy B Tinkle, Nicholas Edwardson, Jamie W Krashin, et al.
Journal of the American Pharmacists Association : Japha|October 18, 2025
New Mexico community pharmacists' knowledge and perspectives of mifepristone and misoprostol for early pregnancy lossAlexandra Herman, Victoria Y Trujillo, Jamie W Krashin, et al.
Journal of Women'S Health (2002)|February 12, 2020
Assessment of Contraceptive Needs and Improving Access in the U.S.-Affiliated Pacific Islands in the Context of ZikaCaitlin Green, Charity Ntansah, Meghan T Frey, et al.
MMWR. Morbidity and Mortality Weekly Report|September 22, 2017
Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV InfectionNaomi K Tepper, Jamie W Krashin, Kathryn M Curtis, et al.
Obstetrics and Gynecology|June 9, 2017
Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of AbortionJamie W Krashin, Gretchen S Stuart, Joanne Garrett, et al.
American Journal of Obstetrics and Gynecology|May 7, 2014
Prohibiting consent: what are the costs of denying permanent contraception concurrent with abortion care?Jamie W Krashin, Alison B Edelman, Mark D Nichols, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|November 23, 2017
Abortion Surveillance - United States, 2014Tara C Jatlaoui, Jill Shah, Michele G Mandel, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Obstetrics & Gynecology|October 3, 2024
Patient navigation in reproductive healthcareMelissa Schechter, Eve Espey, Jamie W Krashin
Obstetrics and Gynecology Clinics of North America|July 27, 2023
Vaginal Bleeding Before 20 Weeks GestationBrenna Banwarth-Kuhn, Miriam McQuade, Jamie W Krashin
American Journal of Obstetrics and Gynecology|December 7, 2025
Patients prioritize choice for postpartum contraceptionJamie W Krashin, Timothy R Petersen, Eve Espey
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|March 28, 2026
The Shifting Policy Landscape in Reproductive HealthMindy B Tinkle, Nicholas Edwardson, Jamie W Krashin, et al.
Journal of the American Pharmacists Association : Japha|October 18, 2025
New Mexico community pharmacists' knowledge and perspectives of mifepristone and misoprostol for early pregnancy lossAlexandra Herman, Victoria Y Trujillo, Jamie W Krashin, et al.
Journal of Women'S Health (2002)|February 12, 2020
Assessment of Contraceptive Needs and Improving Access in the U.S.-Affiliated Pacific Islands in the Context of ZikaCaitlin Green, Charity Ntansah, Meghan T Frey, et al.
MMWR. Morbidity and Mortality Weekly Report|September 22, 2017
Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV InfectionNaomi K Tepper, Jamie W Krashin, Kathryn M Curtis, et al.
Obstetrics and Gynecology|June 9, 2017
Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of AbortionJamie W Krashin, Gretchen S Stuart, Joanne Garrett, et al.
American Journal of Obstetrics and Gynecology|May 7, 2014
Prohibiting consent: what are the costs of denying permanent contraception concurrent with abortion care?Jamie W Krashin, Alison B Edelman, Mark D Nichols, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|November 23, 2017
Abortion Surveillance - United States, 2014Tara C Jatlaoui, Jill Shah, Michele G Mandel, et al.
Pageof 3